{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:48:14Z","timestamp":1773118094708,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Musculoskeletal Care"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>COVID\u201019 drastically changed healthcare delivery models for rheumatology services. We sought to understand the impact of these changes for patients with Rheumatoid Arthritis (RA) and adult Juvenile Inflammatory Arthritis (AJIA) in established patients and those newly diagnosed during the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 316 participants, a significant proportion regularly used analgesics (45.4%, <jats:italic>n<\/jats:italic>\u00a0=\u00a0119), corticosteroids (17.9%, <jats:italic>n<\/jats:italic>\u00a0=\u00a047) and Non\u2010Steroidal Anti\u2010Inflammatory Drugs [(NSAIDs) (36.6%, <jats:italic>n<\/jats:italic>\u00a0=\u00a096)]. Two thirds of participants (66.5%, <jats:italic>n<\/jats:italic>\u00a0=\u00a0210) did not know their Disease Activity Score\u201028 (DAS28). Of the remaining third, moderate disease activity (12%, <jats:italic>n<\/jats:italic>\u00a0=\u00a038) was most reported. We found that 16.8% (<jats:italic>n<\/jats:italic>\u00a0=\u00a053) felt their condition was managed well during the pandemic. The remainder felt more negatively. For the newly diagnosed cohort, 34.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a010) delayed seeking GP help because of COVID\u201019 concerns. Once assessed, a quarter (24.1%, <jats:italic>n<\/jats:italic>\u00a0=\u00a07) were referred to rheumatology after 4 or more consultations. We found 47% (<jats:italic>n<\/jats:italic>\u00a0=\u00a077) expressed positive opinions on remote consultations, whereas 36% (<jats:italic>n<\/jats:italic>\u00a0=\u00a059) had concerns. The lack of clinical examination (42.5%, <jats:italic>n<\/jats:italic>\u00a0=\u00a025) was flagged. Changing the dynamic from health worker to a patient centred approach was the most wished for improvement (20.3%, <jats:italic>n<\/jats:italic>\u00a0=\u00a064).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most participants did not know their disease activity status, which is of concern. With a push towards patient\u2010centred and patient\u2010led care, education and supported self\u2010management is critically important. There is high use of NSAIDs and corticosteroids. Pathways of care underwent change with subsequent delays in specialist assessment. The introduction of patient\u2010initiated follow\u2010up (PIFU) and virtual consultations further distances healthcare professionals from patients and could affect outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1002\/msc.1772","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:40:41Z","timestamp":1683762041000},"page":"908-915","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Accessing care during the pandemic: A UK wide survey of people with rheumatoid arthritis and adult juvenile inflammatory arthritis during the COVID\u201019 pandemic"],"prefix":"10.1002","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-0010","authenticated-orcid":false,"given":"Rajinder Singh","family":"Andev","sequence":"first","affiliation":[{"name":"Department of Rheumatology Oxford University Hospitals NHS FT  Oxford UK"},{"name":"Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Jacklin","sequence":"additional","affiliation":[{"name":"National Rheumatoid Arthritis Society  Maidenhead Berkshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailsa","family":"Bosworth","sequence":"additional","affiliation":[{"name":"National Rheumatoid Arthritis Society  Maidenhead Berkshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Dubey","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Oxford University Hospitals NHS FT  Oxford UK"},{"name":"Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac266"},{"key":"e_1_2_12_3_1","unstructured":"British Society for Rheumatology. (2021).Rheumatology workforce: A crisis in numbers. [Internet]. Retrieved from:https:\/\/rheumatology.org.uk\/Portals\/0\/Documents\/Policy\/Reports\/BSR\u2010workforce\u2010report\u2010crisis\u2010numbers.pdf"},{"key":"e_1_2_12_4_1","unstructured":"British Society for Rheumatology. (2022).National early inflammatory arthritis audit. [Internet]. Retrieved from:https:\/\/www.rheumatology.org.uk\/practice\u2010quality\/audits\/neiaa"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2015.02.163"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097683"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101657"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.22"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665\u20109913(21)00175\u20102"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584\u2010020\u201000562\u20102"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3306"},{"key":"e_1_2_12_13_1","unstructured":"National Health Service(2023).Digitally\u2010enabled primary and outpatient care will go mainstream across the NHS. [Internet]. Retrieved from:https:\/\/www.longtermplan.nhs.uk\/online\u2010version\/chapter\u20101\u2010a\u2010new\u2010service\u2010model\u2010for\u2010the\u201021st\u2010century\/4\u2010digitally\u2010enabled\u2010primary\u2010and\u2010outpatient\u2010care\u2010will\u2010go\u2010mainstream\u2010across\u2010the\u2010nhs\/#:~:text=4.\u2010 Digitally%2Denabled%20primary%20and%20outpatient%20care%20will%20go%20mainstream%20across set%20out%20in%20Chapter%20Five"},{"key":"e_1_2_12_14_1","unstructured":"National Health Service England. (2023).Patient initiated follow up. [Internet]. Retrieved from:https:\/\/www.england.nhs.uk\/outpatient\u2010transformation\u2010programme\/patient\u2010initiated\u2010follow\u2010up\u2010giving\u2010patients\u2010greater\u2010control\u2010over\u2010their\u2010hospital\u2010follow\u2010up\u2010care\/"},{"key":"e_1_2_12_15_1","unstructured":"National Institute for Health and Care Excellence. (2020a).Rheumatoid arthritis in over 16s. [Internet]. Retrieved from:https:\/\/www.nice.org.uk\/guidance\/qs33"},{"key":"e_1_2_12_16_1","unstructured":"National Institute for Health and Care Excellence. (2020b).Rheumatoid arthritis in adults: Management. [Internet]. Retrieved from:https:\/\/www.nice.org.uk\/guidance\/ng100"},{"key":"e_1_2_12_17_1","unstructured":"National Institute for Health and Care Excellence. (2023).Diagnosis and referral of inflammatory arthritis. [Internet]. Retrieved from:https:\/\/www.nice.org.uk\/about\/what\u2010we\u2010do\/into\u2010practice\/measuring\u2010the\u2010use\u2010of\u2010nice\u2010guidance\/impact\u2010of\u2010our\u2010guidance\/nice\u2010impact\u2010arthritis\/diagnosis\u2010and\u2010referral\u2010of\u2010inflammatory\u2010arthritis"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa080"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220249"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000783"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac193"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab796"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220418"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102014\u2010206807"}],"container-title":["Musculoskeletal Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/msc.1772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T07:21:11Z","timestamp":1697613671000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/msc.1772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1002\/msc.1772"],"URL":"https:\/\/doi.org\/10.1002\/msc.1772","archive":["Portico"],"relation":{},"ISSN":["1478-2189","1557-0681"],"issn-type":[{"value":"1478-2189","type":"print"},{"value":"1557-0681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"2023-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}